Hypercholesterolaemia and coronary risk

Ker, James A.

dc.contributor.author	Ker, James A.
dc.date.accessioned	2016-06-14T07:55:53Z
dc.date.available	2016-06-14T07:55:53Z
dc.date.issued	2016-05
dc.description.abstract	Studies have shown that only 10.6% of people with hypercholesterolaemia receive a statin or treatment. There is a within-person variability of cholesterol measurements and therefore a one-time measurement of cholesterol tends to underestimate the strength of the relationship between cholesterol and coronary heart disease. Multiple cholesterol measurements over time (decades) such as done in some epidemiological studies are therefore important to get an idea of life-time risk of atherosclerosis as the disease develops over decades.	en_ZA
dc.description.department	Internal Medicine	en_ZA
dc.description.librarian	am2016	en_ZA
dc.description.uri	http://www.specialistforum.co.za	en_ZA
dc.identifier.citation	Ker, J 2016, 'The Hypercholesterolaemia and coronary risk', The Specialist Forum, vol. 16, no. 4, pp. 11.	en_ZA
dc.identifier.issn	2218-8282
dc.identifier.uri	http://hdl.handle.net/2263/53109
dc.language.iso	en	en_ZA
dc.publisher	New Media Publishing	en_ZA
dc.rights	© The Specialist Forum	en_ZA
dc.subject	Hypercholesterolaemia	en_ZA
dc.subject	Cardiovascular	en_ZA
dc.subject	Treatment	en_ZA
dc.subject	South Africa (SA)	en_ZA
dc.title	Hypercholesterolaemia and coronary risk	en_ZA
dc.type	Article	en_ZA